132600Global Cooperation Feasibility StudiesClosedFeasibility StudiesInnovate UK1 in 5 of us experience mental health problems during our lifetime but more than 50% of patients don’t receive adequate care when assessed using current methods - leading to risk of further deterioration in well-being, reduction in quality of life, loss of income, family breakdown, and self-harming. SaccScan is a novel point-of- care (PoC) software diagnostic system which has been demonstrated to detect schizophrenia with better than 95% accuracy and has been extended with the same precision to bipolar disorder and major depression illnesses. The software diagnostic tool successfully utilises eye-movement abnormalities as clinical diagnostic biomarkers for serious mental illnesses. The test can be performed within 30 minutes and results produced over the internet at near real-time speed. The purpose of this study is to explore international partnerships for bringing a minimum viable version of the test to market and address the global challenge of improving treatment outcomes through personalising medicine in mental health care.